Skip to main content
Erschienen in: Tumor Biology 4/2015

01.04.2015 | Research Article

Polygala tenuifolia polysaccharide (PTP) inhibits cell proliferation by repressing Bmi-1 expression and downregulating telomerase activity

verfasst von: Fubin Zhang, Xiaowei Song, Li Li, Jingfang Wang, Leyuan Lin, Cong Li, Hongtao Li, Yanju Lv, Yinghua Jin, Ying Liu, Yu Hu, Tao Xin

Erschienen in: Tumor Biology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

In our previous study, we isolated a homogeneous polysaccharide (PTP) with antitumor activity from the roots of Polygala tenuifolia. In view of the close correlation between Bmi-1 expression and progression of ovarian cancer, we intend to elucidate the mechanism of its activity by determining the Bmi-1 expression and the telomerase activity in human ovarian carcinoma OVCAR-3 cells following treatment with PTP at three concentrations of 0.5, 1, and 2 mg/mL for 48 h. MTT and colony-forming assays revealed that PTP had a significant inhibitory effect on the cell growth and colony formation of OVCAR-3 cells. Furthermore, Western blot and real-time PCR analysis showed that PTP inhibited Bmi-1 both in protein and transcript levels. Besides, the telomerase activity in OVCAR-3 cells was also downregulated after PTP treatment for 48 h. Taken together, the inhibitory effect of PTP on the cell growth was at least in part mediated via the downregulation of Bmi-1 expression and the telomerase activity in OVCAR-3 cells, and PTP might be a new candidate for chemotherapeutic agent against human ovarian cancer.
Literatur
1.
Zurück zum Zitat Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2005;20:207–25.CrossRefPubMed Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2005;20:207–25.CrossRefPubMed
2.
Zurück zum Zitat Guppy AE, Nathan PD, Rustin GJ. Epithelial ovarian cancer: a review of current management. Clin Oncol (R Coll Radiol). 2005;17:399–411.CrossRef Guppy AE, Nathan PD, Rustin GJ. Epithelial ovarian cancer: a review of current management. Clin Oncol (R Coll Radiol). 2005;17:399–411.CrossRef
4.
Zurück zum Zitat Bast Jr RC, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, et al. Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res. 2007;174:91–100.CrossRefPubMed Bast Jr RC, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, et al. Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res. 2007;174:91–100.CrossRefPubMed
5.
Zurück zum Zitat Silva JS, Moura MD, Oliveira RA, Diniz MF, Barbosa-Filho JM. Natural product inhibitors of ovarian neoplasia. Phytomedicine. 2003;10:221–32.CrossRefPubMed Silva JS, Moura MD, Oliveira RA, Diniz MF, Barbosa-Filho JM. Natural product inhibitors of ovarian neoplasia. Phytomedicine. 2003;10:221–32.CrossRefPubMed
6.
Zurück zum Zitat Brewer MA, Johoson K, Follen M, Gershenson D, Bast Jr R. Prevention of ovarian cancer: intraepithelial neoplasia. Clin Cancer Res. 2003;9:20–30.PubMed Brewer MA, Johoson K, Follen M, Gershenson D, Bast Jr R. Prevention of ovarian cancer: intraepithelial neoplasia. Clin Cancer Res. 2003;9:20–30.PubMed
7.
Zurück zum Zitat Westfall SD, Nilsson EE, Skinner MK. Role of triptolide as an adjunct chemotherapy for ovarian cancer. Chemotherapy. 2008;54:67–76.CrossRefPubMed Westfall SD, Nilsson EE, Skinner MK. Role of triptolide as an adjunct chemotherapy for ovarian cancer. Chemotherapy. 2008;54:67–76.CrossRefPubMed
8.
Zurück zum Zitat Carr C, Ng J, Wigmore T. The side effects of chemotherapeutic agents. Curr Anaesth Crit Care. 2008;19:70–9.CrossRef Carr C, Ng J, Wigmore T. The side effects of chemotherapeutic agents. Curr Anaesth Crit Care. 2008;19:70–9.CrossRef
9.
Zurück zum Zitat Kim E, Rye PT, Essigmann JM, Croy RG. A bifunctional platinum (II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor. J Inorg Biochem. 2009;103:256–61.CrossRefPubMed Kim E, Rye PT, Essigmann JM, Croy RG. A bifunctional platinum (II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor. J Inorg Biochem. 2009;103:256–61.CrossRefPubMed
10.
Zurück zum Zitat Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92:42–7.CrossRefPubMed Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92:42–7.CrossRefPubMed
11.
Zurück zum Zitat Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat. 2004;85:263–70.CrossRefPubMed Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat. 2004;85:263–70.CrossRefPubMed
12.
Zurück zum Zitat Powell CB, Dibble SL, Dall’Era JE, Cohen I. Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer. 2002;12:214–7.CrossRefPubMed Powell CB, Dibble SL, Dall’Era JE, Cohen I. Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer. 2002;12:214–7.CrossRefPubMed
13.
Zurück zum Zitat Wirth JH, Hudgins JC, Paice JA. Use of herbal therapies to relieve pain: a review of adverse effects. Pain Manag Nurs. 2005;6:145–67.CrossRefPubMed Wirth JH, Hudgins JC, Paice JA. Use of herbal therapies to relieve pain: a review of adverse effects. Pain Manag Nurs. 2005;6:145–67.CrossRefPubMed
14.
Zurück zum Zitat Zhu W, Huang L, Xu X, Qian H, Xu W. Anti-proliferation effect of BMI-1 in U937 cells with siRNA. Int J Mol Med. 2010;25:889–95.CrossRefPubMed Zhu W, Huang L, Xu X, Qian H, Xu W. Anti-proliferation effect of BMI-1 in U937 cells with siRNA. Int J Mol Med. 2010;25:889–95.CrossRefPubMed
15.
Zurück zum Zitat Becker M, Korn C, Sienerth AR, Voswinckel R, Luetkenhaus K, Ceteci F, et al. Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer. PLoS One. 2009;4:4230.CrossRef Becker M, Korn C, Sienerth AR, Voswinckel R, Luetkenhaus K, Ceteci F, et al. Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer. PLoS One. 2009;4:4230.CrossRef
16.
Zurück zum Zitat Sawa M, Yamamoto K, Yokozawa T, Kiyoi H, Hishida A, Kajiguchi T, et al. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int J Hematol. 2005;82:42–7.CrossRefPubMed Sawa M, Yamamoto K, Yokozawa T, Kiyoi H, Hishida A, Kajiguchi T, et al. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int J Hematol. 2005;82:42–7.CrossRefPubMed
17.
Zurück zum Zitat Beà S, Tort F, Pinyol M, Puig X, Hernández L, Hernández S, et al. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 2001;61:2409–12.PubMed Beà S, Tort F, Pinyol M, Puig X, Hernández L, Hernández S, et al. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 2001;61:2409–12.PubMed
18.
Zurück zum Zitat Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast. 2004;13:383–8.CrossRefPubMed Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast. 2004;13:383–8.CrossRefPubMed
19.
Zurück zum Zitat Kim JH, Yoon SY, Kim CN, Joo JH, Moon SK, Choe IS, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett. 2004;203:217–24.CrossRefPubMed Kim JH, Yoon SY, Kim CN, Joo JH, Moon SK, Choe IS, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett. 2004;203:217–24.CrossRefPubMed
20.
Zurück zum Zitat Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 2006;66:6225–32.CrossRefPubMed Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 2006;66:6225–32.CrossRefPubMed
21.
Zurück zum Zitat Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C, et al. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer. 2007;121:1764–70.CrossRefPubMed Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C, et al. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer. 2007;121:1764–70.CrossRefPubMed
22.
Zurück zum Zitat Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer. 2007;96:126–33.CrossRefPubMed Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer. 2007;96:126–33.CrossRefPubMed
23.
Zurück zum Zitat Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death from cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 2005;115:1503–21.CrossRefPubMedPubMedCentral Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death from cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 2005;115:1503–21.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Zhang F, Sui L, Xin T. Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues. Exp Oncol. 2008;30:70–4.PubMed Zhang F, Sui L, Xin T. Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues. Exp Oncol. 2008;30:70–4.PubMed
25.
Zurück zum Zitat Berezovska OP. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle. 2006;5:1886–901.CrossRefPubMed Berezovska OP. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle. 2006;5:1886–901.CrossRefPubMed
26.
Zurück zum Zitat Huang ST, Wang CY, Yang RC, Chu CJ, Wu HT, Pang JH. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells. Phytomedicine. 2010;17:47–54.CrossRefPubMed Huang ST, Wang CY, Yang RC, Chu CJ, Wu HT, Pang JH. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells. Phytomedicine. 2010;17:47–54.CrossRefPubMed
27.
Zurück zum Zitat Park SE, Park C, Kim SH, Hossain MA, Kim MY, Chung HY, et al. Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J Ethnopharmacol. 2009;121:304–12.CrossRefPubMed Park SE, Park C, Kim SH, Hossain MA, Kim MY, Chung HY, et al. Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J Ethnopharmacol. 2009;121:304–12.CrossRefPubMed
28.
Zurück zum Zitat Xin T, Zhang FB, Sui GJ, Jin XM. Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity. Br J Biomed Sci. 2012;6:62–6. Xin T, Zhang FB, Sui GJ, Jin XM. Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity. Br J Biomed Sci. 2012;6:62–6.
29.
Zurück zum Zitat Xin T, Zhang F, Jiang Q, Chen C, Huang D, Li Y, et al. Extraction, purification and antitumor activity of a water-soluble polysaccharide from the roots of Polygala tenuifolia. Carbohydr Polym. 2012;90:1127–31.CrossRefPubMed Xin T, Zhang F, Jiang Q, Chen C, Huang D, Li Y, et al. Extraction, purification and antitumor activity of a water-soluble polysaccharide from the roots of Polygala tenuifolia. Carbohydr Polym. 2012;90:1127–31.CrossRefPubMed
Metadaten
Titel
Polygala tenuifolia polysaccharide (PTP) inhibits cell proliferation by repressing Bmi-1 expression and downregulating telomerase activity
verfasst von
Fubin Zhang
Xiaowei Song
Li Li
Jingfang Wang
Leyuan Lin
Cong Li
Hongtao Li
Yanju Lv
Yinghua Jin
Ying Liu
Yu Hu
Tao Xin
Publikationsdatum
01.04.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2920-y

Weitere Artikel der Ausgabe 4/2015

Tumor Biology 4/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.